TipRanks
Fairchem Organics Ltd (IN:FAIRCHEMOR)
:FAIRCHEMOR
India Market
Want to see IN:FAIRCHEMOR full AI Analyst Report?

Fairchem Organics Ltd (FAIRCHEMOR) AI Stock Analysis

2 Followers

Top Page

IN:FAIRCHEMOR

Fairchem Organics Ltd

(FAIRCHEMOR)

Select Model
Select Model
Select Model
Neutral 47 (OpenAI - Gpt-5.6Sol)
Rating:47Neutral
Price Target:
₹650.00
▼(-15.15% Downside)
Action:Reiterated
Date:10/02/26
The score is held back primarily by weakening financial performance—especially the sharp drop in margins and returns—despite manageable leverage and a FY2026 cash flow rebound. Technicals are broadly neutral with negative MACD and price below key medium-term averages, and valuation is unattractive due to a high P/E with only a modest dividend yield.
Positive Factors
Broad specialty-chemical applications
Exposure across several industrial and consumer-linked applications gives Fairchem Organics multiple end markets for its oleochemical products. This breadth can support business resilience and create opportunities for value-added product adoption beyond any single customer segment.
Negative Factors
Revenue decline and margin compression
Falling revenue combined with sharply weaker margins indicates pressure on demand, pricing, costs, or product mix. If sustained, this reduces earnings resilience and limits the cash available for investment, while weakening the economic benefit of the company’s specialty-product portfolio.
Read all positive and negative factors
Positive Factors
Negative Factors
Broad specialty-chemical applications
Exposure across several industrial and consumer-linked applications gives Fairchem Organics multiple end markets for its oleochemical products. This breadth can support business resilience and create opportunities for value-added product adoption beyond any single customer segment.
Read all positive factors

Fairchem Organics Ltd (FAIRCHEMOR) vs. iShares MSCI India ETF (INDA)

Fairchem Organics Ltd Business Overview & Revenue Model

Company Description
Fairchem Organics Limited, headquartered in Ahmedabad, India, was founded in 2019. This company specializes in the manufacturing and worldwide sale of sophisticated oleochemicals and key nutraceutical components. Its market reach extends across In...
How the Company Makes Money
Fairchem Organics primarily makes money by selling specialty oleochemicals and related chemical products to business customers (B2B). Revenue is generated from (1) manufacturing and sale of oleochemical derivatives and specialty additives—where th...

Fairchem Organics Ltd Financial Statement Overview

Summary
Overall financial quality is pressured by a sharp profitability and ROE decline. The income statement is weak (score 34) with FY2026 revenue down (-3.6%) and net margin falling to ~1.2% from ~4.1% in FY2025 (and much higher in FY2021–FY2024). The balance sheet is acceptable (score 63) with manageable leverage (~0.32x debt/equity) but it is less conservative than prior years and weaker earnings reduce comfort. Cash flow is mixed (score 52): FY2026 recovered to positive operating and free cash flow, but FY2025 was negative and cash conversion has been uneven.
Income Statement
34
Negative
Balance Sheet
63
Positive
Cash Flow
52
Neutral
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue5.05B4.60B5.38B6.21B6.47B6.42B
Gross Profit501.37M355.37M666.52M1.54B1.56B1.78B
EBITDA345.51M220.40M441.21M681.10M729.68M1.05B
Net Income143.81M55.41M219.74M405.00M435.01M679.06M
Balance Sheet
Total Assets0.003.91B4.02B3.34B3.42B3.24B
Cash, Cash Equivalents and Short-Term Investments135.00K12.26M12.86M84.00K838.00K83.00K
Total Debt0.00837.82M630.32M73.18M501.68M620.30M
Total Liabilities-2.63B1.28B997.98M443.77M831.48M919.26M
Stockholders Equity2.63B2.63B3.02B2.90B2.59B2.32B
Cash Flow
Free Cash Flow198.36M229.13M-464.87M563.52M348.89M58.91M
Operating Cash Flow306.58M382.54M-203.78M744.80M496.15M404.85M
Investing Cash Flow-106.46M-140.95M-255.71M-176.25M-144.92M-341.84M
Financing Cash Flow-200.08M-241.53M459.49M-568.55M-351.24M-63.19M

Fairchem Organics Ltd Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price766.10
Price Trends
50DMA
693.21
Negative
100DMA
666.72
Negative
200DMA
637.86
Positive
Market Momentum
MACD
-3.11
Negative
RSI
49.91
Neutral
STOCH
74.88
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:FAIRCHEMOR, the sentiment is Neutral. The current price of 766.1 is above the 20-day moving average (MA) of 646.45, above the 50-day MA of 693.21, and above the 200-day MA of 637.86, indicating a neutral trend. The MACD of -3.11 indicates Negative momentum. The RSI at 49.91 is Neutral, neither overbought nor oversold. The STOCH value of 74.88 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IN:FAIRCHEMOR.

Fairchem Organics Ltd Peers Comparison

Overall Rating
UnderperformOutperform
Sector (55)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
75
Outperform
₹174.49B21.69―0.51%15.75%59.22%
68
Neutral
₹90.11B39.55―0.57%5.11%20.64%
55
Neutral
$6.65B3.83-15.92%6.20%10.91%7.18%
53
Neutral
₹104.13B32.65―0.78%10.96%11.16%
50
Neutral
₹49.23B40.04―0.16%5.47%24.88%
47
Neutral
₹8.50B58.46―0.15%0.14%58.54%
47
Neutral
₹172.64B31.75―0.21%27.05%123.98%
* General Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IN:FAIRCHEMOR
Fairchem Organics Ltd
660.00
-112.10
-14.52%
IN:AARTIIND
AARTI Industries Ltd
464.80
84.91
22.35%
IN:ALKYLAMINE
Alkyl Amines Chemicals Limited
1,741.25
-130.94
-6.99%
IN:ATUL
Atul Limited
5,855.85
-248.06
-4.06%
IN:JUBLINGREA
Jubilant Ingrevia Ltd.
637.35
-24.11
-3.65%
IN:LXCHEM
Laxmi Organic Industries Ltd.
181.90
-32.48
-15.15%

Fairchem Organics Ltd Corporate Events

Fairchem Organics Publishes Q1 FY27 Unaudited Results Extract in Financial Dailies
Jul 28, 2026
Fairchem Organics Ltd has notified the stock exchanges that its Board of Directors approved the unaudited financial results for the quarter ended June 30, 2026, at a meeting held on July 27, 2026. In line with regulatory requirements, an extract o...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 02, 2026